This technique is primarily recommended for patients with locally advanced prostate tumours and the elderly. However, due to its demonstrated effectiveness and the excellent results that have been obtained, the range of diagnoses it is indicated for has been expanded and it is now one of a range of techniques that are recommended by both the European Association of Urology and the FDA.
It is a minimally invasive treatment that involves the destruction of the tumour through the cooling of the prostate gland.
Cryotherapy uses freezing at a temperature of -40ºC as a mechanism for cellular destruction. The advantages of this technique include:
-
- Reduction of hospitalisation time
- Drastic reduction of postoperative consequences
- Minimal blood loss
- Can be repeated in the event of cancer recurrence